AIDS

1. ISMAIL A, Garba I, Muhammad AR, Dede H, et al
   Elevated cardiovascular risk in people living with HIV: the association with coronary artery calcification and endothelial dysfunction.
   AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004414.
   

   >> Share

   
   
2. SADINSKI LM, Edwards JK, Herce ME, Avery CL, et al
   Blood pressure trajectories among people with and without HIV in a US-based prospective cohort study.
   AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004387.
   

   >> Share

   
   
3. ZHU W, Huang YA, Patel RR, Kourtis AP, et al
   Suboptimal laboratory testing at PrEP initiation in the United States, 2022-2023.
   AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004413.
   

   >> Share

   
   
4. ARMSTRONG E, Seo E, Boyachuk B, Loutfy M, et al
   Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohort.
   AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004412.
   

   >> Share

   
   

   
   Am J Epidemiol

5. AMORIM G, Slone J, Semeere A, Diero L, et al
   Data validation in multinational observational studies with error-prone data: applying an optimal validation sampling strategy in a study of Kaposi sarcoma and HIV.
   Am J Epidemiol. 2025 Nov 25:kwaf264. doi: 10.1093.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

6. ARORA P, Hindman JT, West S, Ling J, et al
   The effect of antacid and mineral supplements on bictegravir pharmacokinetics: results from a Phase 1, open-label, drug-drug interaction study.
   Antimicrob Agents Chemother. 2025 Nov 28:e0078125. doi: 10.1128/aac.00781.
   

   >> Share

   
   

   
   BMC Cancer

7. DAWOOD S, McMillan B, Brown K, Oosthuizen J, et al
   Early-stage Hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes.
   BMC Cancer. 2025;25:1813.
   

   >> Share

   
   

   
   BMJ

8. SCHUTZ E
   "Miraculous" HIV drug to be rolled out after overcoming aid cuts threat.
   BMJ. 2025;391:r2452.
   

   >> Share

   
   

   
   Clin Infect Dis

9. ERLANDSON KM, Kitch DW, Kantor A, Belaunzaran-Zamudio PF, et al
   The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV.
   Clin Infect Dis. 2025 Nov 26:ciaf652. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

10. HERNANDEZ-PEREIRA M, Du J, Soldado-Folgado J, Carbonell I, et al
    Cross-sectional comparison of cardiovascular risk scores in people with HIV.
    HIV Med. 2025 Nov 21. doi: 10.1111/hiv.70152.
    

    >> Share

    
    
11. SEBOK-SYER SS, Tapper AR, Pasao MA, Nawy RN, et al
    Barriers and mitigating strategies to routine HIV screening in emergency departments: A national qualitative study.
    HIV Med. 2025 Nov 21. doi: 10.1111/hiv.70150.
    

    >> Share

    
    
12. TEH HS, Tay KH, Lim YMF, Yang SL, et al
    Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis.
    HIV Med. 2025 Nov 24. doi: 10.1111/hiv.70145.
    

    >> Share

    
    
13. PROTOPAPAS K, Moschopoulos CD, Kalesis N, Mameletzis I, et al
    Informal PrEP use in Greece: The long, hard road to formal programmatic implementation.
    HIV Med. 2025 Nov 28. doi: 10.1111/hiv.70158.
    

    >> Share

    
    
14. ZHU JC, Hu WP, Zhang J
    Identification of GSR and CBR1 as biomarkers in HIV-associated emphysema through transcriptomic analysis.
    HIV Med. 2025 Nov 28. doi: 10.1111/hiv.70153.
    

    >> Share

    
    

    
    J Clin Invest

15. DONALDSON A, Druker MR, Monaco MC, Stack EH, et al
    Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells.
    J Clin Invest. 2025 Nov 25:e195764. doi: 10.1172/JCI195764.
    

    >> Share

    
    

    
    J Infect Dis

16. CHAPPELL KJ, Mordant FL, Amarilla AA, Modhiran N, et al
    Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial.
    J Infect Dis. 2025 Nov 25:jiaf568. doi: 10.1093.
    

    >> Share

    
    
17. CLARK ES, Garrido G, Levay A, Schrand B, et al
    Vaccination against pathogens targeting cell-derived cryptic antigens.
    J Infect Dis. 2025 Nov 24:jiaf593. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

18. GOPAL K, Burnett C, Kharytonchyk S, Emery A, et al
    RNA splicing patterns contribute to burst size variation among HIV-1-infected Jurkat cell clones.
    J Virol. 2025 Nov 24:e0133425. doi: 10.1128/jvi.01334.
    

    >> Share

    
    
19. SHI M, Chen R, Wu T, Liao Y, et al
    Single-cell transcriptome profiling reveals immunological fitness of HIV long-term non-progressors.
    J Virol. 2025 Nov 24:e0159725. doi: 10.1128/jvi.01597.
    

    >> Share

    
    
20. LODGE R, Kmiec D, Kirchhoff F, Cohen EA, et al
    HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages.
    J Virol. 2025 Nov 24:e0166325. doi: 10.1128/jvi.01663.
    

    >> Share

    
    
21. ANANG S, Zhang S, Ennis A, Ding H, et al
    Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles.
    J Virol. 2025 Nov 26:e0158525. doi: 10.1128/jvi.01585.
    

    >> Share

    
    
22. WEBB NE, Gorman MJ, Parker LJ, Jung W, et al
    The functional antibody landscape in HIV post-treatment controllers is heterogeneous.
    J Virol. 2025 Nov 28:e0179025. doi: 10.1128/jvi.01790.
    

    >> Share

    
    

    
    JAMA

23. HSU M, Shah A, Jordan A, Gold MS, et al
    Therapeutic Use of Cannabis and Cannabinoids: A Review.
    JAMA. 2025 Nov 26. doi: 10.1001/jama.2025.19433.
    

    >> Share

    
    

    
    PLoS Comput Biol

24. XU S, Hudson A, Janes HE, Tomaras GD, et al
    Candidate correlates of protection in the HVTN505 HIV-1 vaccine efficacy trial identified by positive-unlabeled learning.
    PLoS Comput Biol. 2025;21:e1013705.
    

    >> Share

    
    
25. GUANG A, Dunn CW, Novitsky V, Howison M, et al
    T-shaped alignments integrating HIV-1 near full-length genome and partial pol sequences can improve phylogenetic inference of transmission clusters.
    PLoS Comput Biol. 2025;21:e1013676.
    

    >> Share

    
    

    
    PLoS One

26. AURPIBUL L, Saisaengjan C, Songtaweesin WN, Masurin S, et al
    Understanding the challenges of healthcare transition in the context of HIV-related stigma for young adults with perinatal HIV in Thailand.
    PLoS One. 2025;20:e0336624.
    

    >> Share

    
    
27. FENTA A, Dilnessa T, Kebede D, Belayneh M, et al
    Incidence and predictors of mortality among TB-HIV co-infected individuals on anti-tuberculosis and anti-retroviral dual therapy in Northwest Ethiopia: A retrospective cohort study.
    PLoS One. 2025;20:e0337612.
    

    >> Share

    
    
28. CHO FN, Ndim MCF, Tongwa DZ, Tatah CA, et al
    Knowledge, attitudes, and barriers to HIV testing among youth in Kumba, Cameroon: A cross-sectional qualitative community-based focus group study.
    PLoS One. 2025;20:e0337099.
    

    >> Share

    
    
29. PAUL S, Dayal R, Sharma AJ, Seth K, et al
    Unpacking vulnerability to sexually transmitted infections (STIs)/human immunodeficiency virus (HIV) among adolescent girls and young women in India: A qualitative study.
    PLoS One. 2025;20:e0336593.
    

    >> Share

    
    

    
    PLoS Pathog

30. STRUYVE T, Pardons M, De Clercq J, Termote L, et al
    Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people.
    PLoS Pathog. 2025;21:e1013702.
    

    >> Share

    
    

    
    Vaccine

31. CHAVES SS, Castells VB, Wague S, Tian Z, et al
    Chlamydia vaccine willingness among young adults in Australia.
    Vaccine. 2025;70:128027.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share